Anterior ethmoidal glycerol rhizotomy for vasomotor rhinitis.
The treatment of vasomotor rhinitis by anterior ethmoidal glycerol rhizotomy (AEGR) was assessed in 78 patients with a follow-up period ranging from 12 to 15 months. The reduction of nasal hypersecretion obtained with AEGR was maintained over six months. At the final assessment, sixty patients (76.9%) reported complete relief of symptoms and are taking no medications; seven (8.9%) were improved with minimal drug therapy required for symptom relief; and 11.9% had poor results with unsatisfactory control even with medication. Nineteen patients required a second treatment because of an initial suboptimal infection or recurrence. Apparently, this method offers those patients with vasomotor rhinitis a valid option for treatment of clinical symptoms, with the additional benefit of experiencing no serious complications when compared with vidian neurectomy.
Yue
W L
WL
Department of Otolaryngology, Pingdingshan People's Hospital No. 1, Henan, People's Republic of China.
D000328:Adult; D000368:Aged; D003391:Cranial Nerves / Q000187:drug effects*; D005260:Female; D005500:Follow-Up Studies; D005990:Glycerol / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009297:Nasal Mucosa / Q000294:innervation*; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D012223:Rhinitis, Vasomotor / Q000188:drug therapy*; D016896:Treatment Outcome
D005990:Glycerol